The Latest Headlines at American Banking and Market News
William Blair Weighs in on Verve Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:VERV)
Verve Therapeutics, Inc. (NASDAQ:VERV – Free Report) – Analysts at William Blair upped their Q2 2024 EPS estimates for Verve Therapeutics in a research note issued on Wednesday, May 8th. William Blair analyst M. Minter... More of this article »
Village Farms International, Inc. (NASDAQ:VFF) to Post Q2 2024 Earnings of ($0.02) Per Share, Alliance Global Partners Forecasts
Village Farms International, Inc. (NASDAQ:VFF – Free Report) – Investment analysts at Alliance Global Partners issued their Q2 2024 earnings per share estimates for Village Farms International in a note issued to investors... More of this article »
Village Farms International, Inc. Expected to Earn Q2 2024 Earnings of ($0.05) Per Share (NASDAQ:VFF)
Village Farms International, Inc. (NASDAQ:VFF – Free Report) – Equities research analysts at Atb Cap Markets decreased their Q2 2024 earnings per share estimates for Village Farms International in a note issued to investors... More of this article »
Research Analysts Set Expectations for Vigil Neuroscience, Inc.’s Q2 2024 Earnings (NASDAQ:VIGL)
Vigil Neuroscience, Inc. (NASDAQ:VIGL – Free Report) – Wedbush raised their Q2 2024 earnings estimates for shares of Vigil Neuroscience in a research note issued on Wednesday, May 8th. Wedbush analyst L. Chico now expects... More of this article »
Q2 2024 EPS Estimates for Virtu Financial, Inc. (NASDAQ:VIRT) Boosted by Analyst
Virtu Financial, Inc. (NASDAQ:VIRT – Free Report) – Stock analysts at Zacks Research lifted their Q2 2024 earnings estimates for shares of Virtu Financial in a research note issued to investors on Wednesday, May 8th.... More of this article »
Brokers Set Expectations for Viridian Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:VRDN)
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Stock analysts at Leerink Partnrs lifted their Q2 2024 earnings per share (EPS) estimates for shares of Viridian Therapeutics in a research report issued to clients... More of this article »
Viridian Therapeutics, Inc. Forecasted to Earn Q2 2024 Earnings of ($0.80) Per Share (NASDAQ:VRDN)
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Equities research analysts at Wedbush increased their Q2 2024 earnings per share (EPS) estimates for shares of Viridian Therapeutics in a research note issued... More of this article »
Q2 2024 Earnings Forecast for Viridian Therapeutics, Inc. (NASDAQ:VRDN) Issued By HC Wainwright
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Stock analysts at HC Wainwright lifted their Q2 2024 earnings estimates for Viridian Therapeutics in a research report issued to clients and investors on Thursday,... More of this article »
B. Riley Comments on Viridian Therapeutics, Inc.’s Q2 2024 Earnings (NASDAQ:VRDN)
Viridian Therapeutics, Inc. (NASDAQ:VRDN – Free Report) – Investment analysts at B. Riley increased their Q2 2024 EPS estimates for shares of Viridian Therapeutics in a research note issued on Thursday, May 9th. B.... More of this article »
Brokers Offer Predictions for Curaleaf Holdings, Inc.’s Q1 2024 Earnings (OTCMKTS:CURLF)
Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Investment analysts at Seaport Res Ptn cut their Q1 2024 earnings per share (EPS) estimates for Curaleaf in a research note issued on Thursday, May 9th. Seaport... More of this article »
Roth Capital Research Analysts Decrease Earnings Estimates for Verano Holdings Corp. (OTCMKTS:VRNOF)
Verano Holdings Corp. (OTCMKTS:VRNOF – Free Report) – Roth Capital dropped their Q2 2024 earnings estimates for shares of Verano in a report released on Thursday, May 9th. Roth Capital analyst S. Fortune now expects... More of this article »
Q2 2024 EPS Estimates for Zevia PBC Lowered by Telsey Advisory Group (NYSE:ZVIA)
Zevia PBC (NYSE:ZVIA – Free Report) – Equities researchers at Telsey Advisory Group dropped their Q2 2024 earnings estimates for shares of Zevia PBC in a note issued to investors on Thursday, May 9th. Telsey Advisory... More of this article »
Q2 2024 EPS Estimates for Willis Towers Watson Public Limited Cut by Zacks Research (NASDAQ:WTW)
Willis Towers Watson Public Limited (NASDAQ:WTW – Free Report) – Stock analysts at Zacks Research lowered their Q2 2024 earnings estimates for shares of Willis Towers Watson Public in a report issued on Thursday, May... More of this article »